Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-11-26 07:30 |
Pharming announces receipt of US$10 million milestone payment
|
English | 183.4 KB | ||
| 2012-11-07 08:40 |
Pharming concludes third call of €10 million equity working capital facility
|
English | 64.9 KB | ||
| 2012-11-07 07:52 |
Santarus and Pharming announce positive top-line Phase III results for Ruconest…
|
English | 145.7 KB | ||
| 2012-11-01 08:13 |
Pharming reports on financials results third quarter 2012
|
English | 503.2 KB | ||
| 2012-11-01 07:05 | English | 503.2 KB | |||
| 2012-10-31 08:27 |
Pharming announces publication of Ruconest HAE prophylaxis study
|
English | 166.4 KB | ||
| 2012-10-26 08:28 |
Pharming provides update on ongoing call of third tranche of €10 million equity…
|
English | 89.0 KB | ||
| 2012-10-22 08:32 |
Pharming provides update on ongoing call of third tranche of €10 million equity…
|
English | 185.4 KB | ||
| 2012-10-19 08:37 |
Pharming provides update on ongoing call of third tranche of €10 milion equity …
|
English | 185.6 KB | ||
| 2012-10-18 08:21 |
Pharming provides update on ongoing call of third tranche of €10 million equity…
|
English | 187.0 KB | ||
| 2012-10-17 08:26 |
Pharming draws third tranche under €10 million equity working capital facility
|
English | 191.6 KB | ||
| 2012-10-15 07:46 |
Pharming provides update on outstanding shares
|
English | 156.4 KB | ||
| 2012-10-10 08:45 |
Pharming provides update on outstanding shares
|
English | 159.8 KB | ||
| 2012-09-27 08:47 |
Pharming Completes Ruconest® US Pivotal Phase III Study
|
English | 138.9 KB | ||
| 2012-09-26 08:45 |
Pharming concludes second call of €10 million equity working capital facility
|
English | 187.5 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
